| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Case of HLA-DRB1-MET Rearranged Lung Adenocarcinoma With Rapid Response to Crizotinib
|
Kunte, Siddharth
|
|
|
22 |
3 |
p. e298-e300
|
artikel
|
| 2 |
A Phase II Study of Telisotuzumab Vedotin in Patients With c–MET-positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP Sub-study S1400K, NCT03574753)
|
Waqar, Saiama N.
|
|
|
22 |
3 |
p. 170-177
|
artikel
|
| 3 |
Association of Extended Dosing Intervals or Delays in Pembrolizumab-based Regimens With Survival Outcomes in Advanced Non–small-cell Lung Cancer
|
Sehgal, Kartik
|
|
|
22 |
3 |
p. e379-e389
|
artikel
|
| 4 |
Brazilian Women With Lung Cancer Have a Higher Overall Survival Than Their Male Equivalents: A Cohort Study
|
Costa, Guilherme Jorge
|
|
|
22 |
3 |
p. e313-e319
|
artikel
|
| 5 |
Bronchial Arterial Infusion Chemotherapy Plus Drug-eluting Bead Chemoembolization for Recurrence of Carina Region-induced Severe Right Main Bronchial Stenosis After Pneumonectomy
|
Zeng, Yan-Wei
|
|
|
22 |
3 |
p. e293-e297
|
artikel
|
| 6 |
Clinical Outcomes and Predictors of Lung Toxicity After Multiple Courses of Lung Stereotactic Body Radiotherapy for Early-Stage Non–Small Cell Lung Cancer
|
Muller, Donald A.
|
|
|
22 |
3 |
p. 234-241
|
artikel
|
| 7 |
Clinicopathologic Significance of False-Positive Lymph Node Status on FDG-PET in Lung Cancer
|
Endoh, Hideki
|
|
|
22 |
3 |
p. 218-224
|
artikel
|
| 8 |
Combining Osimertinib With Chemotherapy in EGFR-Mutant NSCLC at Progression
|
White, Maya N
|
|
|
22 |
3 |
p. 201-209
|
artikel
|
| 9 |
Considerations for the Surgical Management of Early Stage Lung Cancer During the COVID-19 Pandemic
|
Merritt, Robert E.
|
|
|
22 |
3 |
p. 156-160
|
artikel
|
| 10 |
Cutaneous Toxicities in Lung Cancer Patients on Immune Checkpoint Inhibitor Therapy
|
Keiser, Monika F.
|
|
|
22 |
3 |
p. 195-200.e1
|
artikel
|
| 11 |
Delayed-Phase Enhancement for Evaluation of Malignant Pleural Mesothelioma on Computed Tomography: A Prospective Cohort Study
|
Patel, Akash
|
|
|
22 |
3 |
p. 210-217.e1
|
artikel
|
| 12 |
Editorial Board
|
|
|
|
22 |
3 |
p. A4
|
artikel
|
| 13 |
Efficacy of Osimertinib in Afatinib-resistant Lung Cancer Harboring Uncommon EGFR Mutations: Case Report and Literature Review
|
Zhao, Yuanyuan
|
|
|
22 |
3 |
p. e466-e469
|
artikel
|
| 14 |
EGFR Tyrosine Kinase Inhibitor (TKI) Combined With Concurrent or Sequential Chemotherapy for Patients With Advanced Lung Cancer and Gradual Progression After First-Line EGFR-TKI Therapy: A Randomized Controlled Study
|
Chang, Qing
|
|
|
22 |
3 |
p. e395-e404
|
artikel
|
| 15 |
External Validation of AJCC Eighth Edition of Non–small-cell Lung Cancer Staging Among African Americans
|
Uprety, Dipesh
|
|
|
22 |
3 |
p. e371-e378
|
artikel
|
| 16 |
Factors Associated With Aggressiveness of End-of-Life Care for Lung Cancer Patients and Associated Costs of Care
|
Bylicki, Olivier
|
|
|
22 |
3 |
p. e320-e328
|
artikel
|
| 17 |
Female Gender Predicts Augmented Immune Infiltration in Lung Adenocarcinoma
|
Behrens, Carmen
|
|
|
22 |
3 |
p. e415-e424
|
artikel
|
| 18 |
Giant Circulating Cancer-Associated Macrophage-Like Cells Are Associated With Disease Recurrence and Survival in Non–Small-Cell Lung Cancer Treated With Chemoradiation and Atezolizumab
|
Augustyn, Alexander
|
|
|
22 |
3 |
p. e451-e465
|
artikel
|
| 19 |
Impact of Lung Parenchymal-Only Failure on Overall Survival in Early-Stage Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy
|
Elbanna, May
|
|
|
22 |
3 |
p. e342-e359
|
artikel
|
| 20 |
Impact of Radiotherapy on the Efficacy and Toxicity of anti-PD-1 Inhibitors in Metastatic NSCLC
|
Samuel, Evangeline
|
|
|
22 |
3 |
p. e425-e430
|
artikel
|
| 21 |
Long-Term Outcomes After Sublobar Resection Versus Lobectomy in Patients With Clinical Stage IA Lung Adenocarcinoma Meeting the Node-Negative Criteria Defined by High-Resolution Computed Tomography and [18F]-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography
|
Tsutani, Yasuhiro
|
|
|
22 |
3 |
p. e431-e437
|
artikel
|
| 22 |
Lung Adenocarcinoma Harboring Concomitant EGFR Mutations and BRAF V600E Responds to a Combination of Osimertinib and Vemurafenib to Overcome Osimertinib Resistance
|
Xie, Zhanhong
|
|
|
22 |
3 |
p. e390-e394
|
artikel
|
| 23 |
Next-Generation Sequencing Identified a Novel Crizotinib-Sensitive PLB1-ALK Rearrangement in Lung Large-Cell Neuroendocrine Carcinoma
|
Wang, Shuai
|
|
|
22 |
3 |
p. e366-e370
|
artikel
|
| 24 |
Novel Clinical Trial Designs in Pursuit of Precision Oncology: Lung-MAP As a Model
|
Riess, Jonathan W.
|
|
|
22 |
3 |
p. 153-155
|
artikel
|
| 25 |
Older Patients Treated for Lung and Thoracic Cancers: Unplanned Hospitalizations and Overall Survival
|
Couderc, Anne-Laure
|
|
|
22 |
3 |
p. e405-e414
|
artikel
|
| 26 |
Oncologic Outcomes of Surgery Versus SBRT for Non–Small-Cell Lung Carcinoma: A Systematic Review and Meta-analysis
|
Ijsseldijk, Michiel A.
|
|
|
22 |
3 |
p. e235-e292
|
artikel
|
| 27 |
PD-1/PD-L1 Checkpoint Inhibitor Immunotherapy for Malignant Pleural Mesothelioma: Case Series and Literature Review
|
Zhou, Maggie
|
|
|
22 |
3 |
p. e329-e335
|
artikel
|
| 28 |
Phase 2 Study of Talazoparib in Patients With Homologous Recombination Repair–Deficient Squamous Cell Lung Cancer: Lung-MAP Substudy S1400G
|
Owonikoko, Taofeek K.
|
|
|
22 |
3 |
p. 187-194.e1
|
artikel
|
| 29 |
Postoperative Radiotherapy for Locally Advanced NSCLC: Implications for Shifting to Conformal, High-Risk Fields
|
Chapman, Bhavana V.
|
|
|
22 |
3 |
p. 225-233.e7
|
artikel
|
| 30 |
Prospective Observational Study of Treatment Resistance-related Gene Screening Using Plasma Circulating Tumor DNA in Third-generation EGFR-TKI Osimertinib Therapy (Elucidator)
|
Tamiya, Akihiro
|
|
|
22 |
3 |
p. e336-e341
|
artikel
|
| 31 |
Pulmonary Adenocarcinoma Metastasis to the Breast Unexpectedly Discovered on Re-staging 18F-FDG PET/CT in a Woman With a Normal Screening Mammogram
|
Kozlov, Andrew
|
|
|
22 |
3 |
p. e438-e441
|
artikel
|
| 32 |
Recent Advances in the Management of Typical and Atypical Lung Carcinoids
|
Prinzi, Natalie
|
|
|
22 |
3 |
p. 161-169
|
artikel
|
| 33 |
Regarding: MicroRNA-126 Targeting PIK3R2 Inhibits NSCLC A549 Cell Proliferation, Migration, and Invasion by Regulation of PTEN/PI3K/AKT Pathway
|
Peng, Li-Ping
|
|
|
22 |
3 |
p. e446-e450
|
artikel
|
| 34 |
Response to the Selective RET Inhibitor Selpercatinib (LOXO-292) in a Patient With RET Fusion-positive Atypical Lung Carcinoid
|
Kander, Elizabeth M.
|
|
|
22 |
3 |
p. e442-e445
|
artikel
|
| 35 |
Salvage Stereotactic Body Radiation Therapy for Isolated Local Recurrence After Primary Surgical Resection of Non–small-cell Lung Cancer
|
Sittenfeld, Sarah M.C.
|
|
|
22 |
3 |
p. e360-e365
|
artikel
|
| 36 |
Successful Drug Rechallenge Following Severe Acute Alectinib-induced Interstitial Lung Disease in a Patient With Advanced ALK-rearranged Lung Adenocarcinoma
|
Gadotti, Luiza Lara
|
|
|
22 |
3 |
p. e481-e486
|
artikel
|
| 37 |
SWOG S1400A (NCT02154490): A Phase II Study of Durvalumab for Patients With Previously Treated Stage IV or Recurrent Squamous Cell Lung Cancer (Lung-MAP Sub-study)
|
Borghaei, Hossein
|
|
|
22 |
3 |
p. 178-186
|
artikel
|
| 38 |
Table of Contents
|
|
|
|
22 |
3 |
p. A5-A8, A25-A27
|
artikel
|
| 39 |
Ultra-central Thoracic Re-irradiation Using 10-fraction Stereotactic Body Radiotherapy for Recurrent Non–small-cell Lung Cancer Tumors: Preliminary Toxicity and Efficacy Outcomes
|
Sood, Sumit
|
|
|
22 |
3 |
p. e301-e312
|
artikel
|
| 40 |
Utilization Trends and Factors Associated With ROS1 Testing Among Patients With Advanced Non–small-cell Lung Cancer in US Community Practices
|
Wong, William
|
|
|
22 |
3 |
p. e470-e480
|
artikel
|
| 41 |
What Goals Do Patients and Oncologists Have When Starting Medical Treatment for Metastatic Lung Cancer?
|
Mieras, Adinda
|
|
|
22 |
3 |
p. 242-251.e5
|
artikel
|
Tijdschrift beschrijving